{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:21:02Z","timestamp":1791192062242,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.bbagen.2015.03.014","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T15:58:59Z","timestamp":1428422339000},"page":"1426-1437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Expression in yeast, new substrates, and construction of a first 3D model of human orphan cytochrome P450 2U1: Interpretation of substrate hydroxylation regioselectivity from docking studies"],"prefix":"10.1016","volume":"1850","author":[{"given":"Lionel","family":"Ducassou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Jonasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dhers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pietrancosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Booma","family":"Ramassamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu-Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Loriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Beaune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gildas","family":"Bertho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"Lombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mansuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2015.03.014_bb0005","series-title":"Cytochrome P450: Structure, Mechanism and Biochemistry","author":"Ortiz de Montellano","year":"2005"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0010","series-title":"Cytochrome P450: Structure, Mechanism and Biochemistry","first-page":"377","article-title":"Human cytochrome P450 enzymes","author":"Guengerich","year":"2005"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1124\/pr.110.003525","article-title":"Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology","volume":"63","author":"Guengerich","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.taap.2004.12.022","article-title":"Novel extrahepatic cytochrome P450s","volume":"207","author":"Karlgren","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2004.01.110","article-title":"Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1","volume":"315","author":"Karlgren","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0030","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1074\/jbc.M311830200","article-title":"CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids","volume":"279","author":"Chuang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0035","first-page":"280","article-title":"Cytochrome P450 CYP2 genes in the common cormorant: evolutionary relationships with 130 diapsid CYP2 clan sequences and chemical effects on their expression","volume":"153","author":"Kubota","year":"2011","journal-title":"Comp. Biochem. Physiol. C: Toxicol. Pharmacol."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/1471-2164-11-643","article-title":"Identification and developmental expression of the full complement of cytochrome P450 genes in zebrafish","volume":"11","author":"Goldstone","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0045","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1124\/dmd.109.027011","article-title":"Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function","volume":"37","author":"Dutheil","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.plefa.2010.06.005","article-title":"Genetic polymorphism of CYP2U1, a cytochrome P450 involved in fatty acids hydroxylation","volume":"83","author":"Devos","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0055","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/mp200129p","article-title":"Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels","volume":"8","author":"Shawahna","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0060","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/138920011798357024","article-title":"Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood\u2013brain barrier","volume":"12","author":"Decleves","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0065","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/FPC.0b013e32810f2e58","article-title":"Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues","volume":"17","author":"Bi\u00e8che","year":"2007","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/dmd.109.029249","article-title":"Xenobiotic-metabolizing cytochromes P450 in human white adipose tissue: expression and induction","volume":"38","author":"Ellero","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.plefa.2013.06.008","article-title":"Identification of cytochromes P450s involved in the metabolism of arachidonic acid in human platelets","volume":"89","author":"Jarrar","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0080","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2559.2010.03606.x","article-title":"Profiling the expression of cytochrome P450 in breast cancer","volume":"57","author":"Murray","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0085","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1158\/1078-0432.CCR-04-1848","article-title":"Cytochrome P450 profile of colorectal cancer: identification of markers of prognosis","volume":"11","author":"Kumarakulasingham","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0090","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ajhg.2012.11.001","article-title":"Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia","volume":"91","author":"Tesson","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0095","doi-asserted-by":"crossref","first-page":"10476","DOI":"10.1074\/jbc.M114.550004","article-title":"Oxidation of endogenous N-arachidonoylserotonin by human cytochrome P450 2U1","volume":"289","author":"Siller","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0100","first-page":"289","article-title":"Treatment of hypertension with debrisoquine sulfate (Declinax)","volume":"7","author":"Luria","year":"1965","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0105","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0076-6879(91)06120-R","article-title":"Bufuralol, dextromethorphan, and debrisoquine as prototype substrates for human P450IID6","volume":"206","author":"Kronbach","year":"1991","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/004982500237622","article-title":"Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modelling","volume":"30","author":"Lightfoot","year":"2000","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0115","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0090-9556(25)07393-3","article-title":"Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation","volume":"21","author":"Yun","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0120","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/j.bmcl.2006.02.004","article-title":"Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2","volume":"16","author":"Lafite","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.abb.2007.03.028","article-title":"Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2","volume":"464","author":"Lafite","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0130","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1021\/bi700876a","article-title":"Unusual regioselectivity and active site topology of human cytochrome P450 2J2","volume":"46","author":"Lafite","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0135","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/S0040-4039(00)79163-5","article-title":"Urethane protected derivatives of 1-Guanylpyrazole for the mild and efficient preparation of guanidines","volume":"34","author":"Bernatowicz","year":"1993","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1124\/dmd.111.041566","article-title":"Debrisoquine metabolism and CYP2D expression in marmoset liver microsomes","volume":"40","author":"Cooke","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0076-6879(96)72008-6","article-title":"Yeast expression of animal and plant P450s in optimized redox environments","volume":"272","author":"Pompon","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0150","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1042\/bst0211028","article-title":"Xenobiotic metabolism in humanized yeast: engineered yeast cells producing human NADPH-cytochrome P-450 reductase, cytochrome b5, epoxide hydrolase and P-450s","volume":"21","author":"Urban","year":"1993","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1432-1033.1992.tb17027.x","article-title":"Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5","volume":"207","author":"Peyronneau","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0165","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nprot.2009.121","article-title":"Measurement of cytochrome P450 and NADPH cytochrome P450 reductase","volume":"4","author":"Guengerich","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0170","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/prot.340230306","article-title":"Evaluation of comparative protein modeling by modeller","volume":"23","author":"Sali","year":"1995","journal-title":"Proteins"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"Procheck \u2014 a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0180","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/381272a0","article-title":"Errors in protein structures","volume":"381","author":"Hooft","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0185","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0190","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1126\/science.1853201","article-title":"A method to identify protein sequences that fold into a known three-dimensional structure","volume":"253","author":"Bowie","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0195","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0200","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jcc.20221","article-title":"New AMBER force field parameters of heme iron for cytochrome P450s determined by quantum chemical calculations of simplified models","volume":"26","author":"Oda","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jcc.21922","article-title":"Quantum mechanically derived AMBER-compatible heme parameters for various states of the cytochrome P450 catalytic cycle","volume":"33","author":"Shahrokh","year":"2012","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0210","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1107\/S0907444993011333","article-title":"Detection, delineation, measurement and display of cavities in macromolecular structures","volume":"50","author":"Kleywegt","year":"1994","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0215","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.str.2007.10.007","article-title":"MOLE: a Voronoi diagram-based explorer of molecular channels, pores, and tunnels","volume":"15","author":"Petrek","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","article-title":"Automated docking of flexible ligands: applications of AutoDock","volume":"9","author":"Goodsell","year":"1996","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0225","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0230","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jcc.10306","article-title":"Detailed analysis of grid-based molecular docking: a case study of CDOCKER \u2014 a CHARMm-based MD docking algorithm","volume":"24","author":"Wu","year":"2003","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0235","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0090-9556(25)05746-0","article-title":"Metabolism of debrisoquine sulfate. Identification of some urinary metabolites in rat and man","volume":"3","author":"Allen","year":"1975","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0240","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0378-4347(00)00402-3","article-title":"Enantioselectivity of debrisoquine 4-hydroxylation in Brazilian Caucasian hypertensive patients phenotyped as extensive metabolizers","volume":"749","author":"Cerqueira","year":"2000","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0245","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2125.1988.tb03335.x","article-title":"Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine","volume":"25","author":"Eichelbaum","year":"1988","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0250","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1124\/dmd.105.008920","article-title":"3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio","volume":"34","author":"Zhen","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0255","first-page":"1096","article-title":"1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humans","volume":"26","author":"Eiermann","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0260","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1124\/dmd.30.9.970","article-title":"Catalytic specificity of CYP2D isoforms in rat and human","volume":"30","author":"Hiroi","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0265","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/0006-2952(93)90616-5","volume":"46","author":"Clement","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0270","series-title":"Cytochrome P450: Structure, Mechanism, and Biochemistry","first-page":"247","article-title":"Inhibition of cytochrome P450 enzymes","author":"Correia","year":"2005"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0275","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0090-9556(25)06633-4","article-title":"Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes","volume":"23","author":"Ling","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0280","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0285","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2105-5-113","article-title":"MUSCLE: a multiple sequence alignment method with reduced time and space complexity","volume":"5","author":"Edgar","year":"2004","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0290","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/prot.20921","article-title":"MUSTANG: a multiple structural alignment algorithm","volume":"64","author":"Konagurthu","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0295","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbagen.2006.07.005","article-title":"The ins and outs of cytochrome P450s","volume":"1770","author":"Cojocaru","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2015.03.014_bb0300","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pcbi.1002152","article-title":"Structure and dynamics of the membrane-bound cytochrome P450 2C9","volume":"7","author":"Cojocaru","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0305","doi-asserted-by":"crossref","first-page":"17227","DOI":"10.1074\/jbc.M802180200","article-title":"Determinants of cytochrome P450 2C8 substrate binding. Structures of complexes with montelukast, troglitazone, felodipine and 9-cis-retinoic acid","volume":"283","author":"Schoch","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0310","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/tx960003i","article-title":"A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108","volume":"9","author":"de Groot","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0315","doi-asserted-by":"crossref","first-page":"29055","DOI":"10.1074\/jbc.270.49.29055","article-title":"Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6","volume":"270","author":"Ellis","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0320","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1021\/jm981118h","article-title":"Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6","volume":"42","author":"de Groot","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0325","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/bj3450565","article-title":"Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6","volume":"345","author":"Ellis","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0330","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1074\/jbc.M209519200","article-title":"Residues glutamate 216 and aspartate 301 are key determinants of substrate specificity and product regioselectivity in cytochrome P450 2D6","volume":"278","author":"Paine","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0335","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1021\/jm0508538","article-title":"Catalytic site prediction and virtual screening of cytochrome P450 2D6 substrates by consideration of water and rescoring in automated docking","volume":"49","author":"de Graaf","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0340","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10822-010-9336-6","article-title":"Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism","volume":"24","author":"Unwalla","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0345","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M511232200","article-title":"Crystal structure of human cytochrome P450 2D6","volume":"281","author":"Rowland","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0350","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1074\/jbc.M111.307918","article-title":"Crystal structure of human cytochrome P450 2D6 with prinomastat bound","volume":"287","author":"Wang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2015.03.014_bb0355","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/prot.21778","article-title":"Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking","volume":"71","author":"Li","year":"2008","journal-title":"Proteins Struct. Funct. Genet."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651500094X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651500094X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T23:52:10Z","timestamp":1747871530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030441651500094X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S030441651500094X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2015.03.014","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression in yeast, new substrates, and construction of a first 3D model of human orphan cytochrome P450 2U1: Interpretation of substrate hydroxylation regioselectivity from docking studies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2015.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}